These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38890719)

  • 1. Inflammation accelerating intestinal fibrosis: from mechanism to clinic.
    Xin S; Liu X; He C; Gao H; Wang B; Hua R; Gao L; Shang H; Sun F; Xu J
    Eur J Med Res; 2024 Jun; 29(1):335. PubMed ID: 38890719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.
    Lovisa S; Genovese G; Danese S
    J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal fibrosis in IBD--a dynamic, multifactorial process.
    Rieder F; Fiocchi C
    Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):228-35. PubMed ID: 19347014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.
    Bettenworth D; Rieder F
    Dig Dis; 2017; 35(1-2):25-31. PubMed ID: 28147352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal Cell Regulation of Intestinal Inflammatory Fibrosis.
    Yang W; Yu T; Cong Y
    Cell Mol Gastroenterol Hepatol; 2024; 17(5):703-711. PubMed ID: 38246590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cytokine and immune responses in intestinal fibrosis.
    Yang B; Zhang G; Elias M; Zhu Y; Wang J
    J Dig Dis; 2020 Jun; 21(6):308-314. PubMed ID: 32410365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of non-inflammatory factors in intestinal fibrosis.
    Zhao JF; Ling FM; Li JR; Chen YD; Huang L; Zhu LR
    J Dig Dis; 2020 Jun; 21(6):315-318. PubMed ID: 32406603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing fibrosis in IBD: update on immune pathways and clinical strategies.
    Wang J; Yang B; Chandra J; Ivanov A; Brown JM; Rieder F
    Expert Rev Clin Immunol; 2024 Jul; 20(7):727-734. PubMed ID: 38475672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and Molecular Mechanisms of Intestinal Fibrosis.
    Wu X; Lin X; Tan J; Liu Z; He J; Hu F; Wang Y; Chen M; Liu F; Mao R
    Gut Liver; 2023 May; 17(3):360-374. PubMed ID: 36896620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic modulation during intestinal fibrosis.
    Bos S; Laukens D
    J Dig Dis; 2020 Jun; 21(6):319-325. PubMed ID: 32406133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease.
    Prados ME; García-Martín A; Unciti-Broceta JD; Palomares B; Collado JA; Minassi A; Calzado MA; Appendino G; Muñoz E
    Acta Pharmacol Sin; 2021 Jul; 42(7):1124-1138. PubMed ID: 32811965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of tissue remodeling in inflammatory bowel disease.
    Rieder F; Fiocchi C
    Dig Dis; 2013; 31(2):186-93. PubMed ID: 24030223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and Molecular Mediators of Intestinal Fibrosis.
    Lawrance IC; Rogler G; Bamias G; Breynaert C; Florholmen J; Pellino G; Reif S; Speca S; Latella G
    J Crohns Colitis; 2017 Dec; 11(12):1491-1503. PubMed ID: 25306501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy.
    Wang Y; Huang B; Jin T; Ocansey DKW; Jiang J; Mao F
    Front Immunol; 2022; 13():835005. PubMed ID: 35370998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we prevent, reduce or reverse intestinal fibrosis in IBD?
    Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the epithelial barrier in intestinal fibrosis associated with inflammatory bowel disease: relevance of the epithelial-to mesenchymal transition.
    Macias-Ceja DC; Mendoza-Ballesteros MT; Ortega-Albiach M; Barrachina MD; Ortiz-Masià D
    Front Cell Dev Biol; 2023; 11():1258843. PubMed ID: 37822869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science.
    Rieder F; Fiocchi C
    Curr Opin Gastroenterol; 2008 Jul; 24(4):462-8. PubMed ID: 18622160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanisms and clinical trial endpoints in intestinal fibrosis.
    Wang J; Lin S; Brown JM; van Wagoner D; Fiocchi C; Rieder F
    Immunol Rev; 2021 Jul; 302(1):211-227. PubMed ID: 33993489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Bamias G; Pizarro TT; Cominelli F
    Inflamm Bowel Dis; 2022 Mar; 28(3):337-349. PubMed ID: 34904152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.